During the corresponding time, Burning Rock Biotech Limited recorded a revenue increase by 9.18 % year on year, While revenue at the Burning Rock Biotech Limited's corporate clients
Burning Rock Biotech Limited's Comment on Sales, Marketing and Customers
The company develops and validates early cancer detection products targeting multiple cancer types, including lung, colorectal, liver, ovarian, pancreatic, and esophageal cancers. It conducts multi-center studies such as PREDICT, PRESCIENT, and PREVENT, focusing on pan-cancer early detection in asymptomatic populations in China. Its product portfolio includes next-generation sequencing (NGS)-based tissue and liquid biopsy tests for cancer therapy selection and prognosis prediction. Notably, the OncoScreen Focus (LungCure CDx) test is approved by the National Medical Products Administration (NMPA) for non-small cell lung cancer patients. The company collaborates with Dizal Pharmaceutical Co., Ltd. on companion diagnostics for lung cancer, including an NMPA-approved companion diagnostic for the EGFR exon 20 insertion mutation.
Burning Rock Biotech Limited’s Comment on Sales, Marketing and Customers
The company develops and validates early cancer detection products targeting multiple cancer types, including lung, colorectal, liver, ovarian, pancreatic, and esophageal cancers. It conducts multi-center studies such as PREDICT, PRESCIENT, and PREVENT, focusing on pan-cancer early detection in asymptomatic populations in China. Its product portfolio includes next-generation sequencing (NGS)-based tissue and liquid biopsy tests for cancer therapy selection and prognosis prediction. Notably, the OncoScreen Focus (LungCure CDx) test is approved by the National Medical Products Administration (NMPA) for non-small cell lung cancer patients. The company collaborates with Dizal Pharmaceutical Co., Ltd. on companion diagnostics for lung cancer, including an NMPA-approved companion diagnostic for the EGFR exon 20 insertion mutation.
Sources:
Burning Rock Biotech Limited’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Burning Rock Biotech Limited’s corporate clients.
For your research, we’ve provided 9 tables on Burning Rock Biotech Limited corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
